Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Colorcon
Cerilliant
Moodys
Express Scripts
Harvard Business School
US Army
Deloitte
Chubb

Generated: December 10, 2018

DrugPatentWatch Database Preview

Drug Price Trends for ACETAMINOPHEN-CODEINE

« Back to Dashboard

Drug Price Trends for ACETAMINOPHEN-CODEINE

Average Pharmacy Cost for ACETAMINOPHEN-CODEINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 50383-0079-16 0.01324 ML 2018-11-21
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 60432-0245-16 0.01324 ML 2018-11-21
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 00121-0504-16 0.01324 ML 2018-11-21
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 60432-0245-16 0.01292 ML 2018-10-17
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 50383-0079-16 0.01292 ML 2018-10-17
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 00121-0504-16 0.01292 ML 2018-10-17
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 00121-0504-04 0.01897 ML 2018-09-19
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
McKinsey
US Department of Justice
Harvard Business School
Fish and Richardson
Cantor Fitzgerald
Citi
QuintilesIMS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.